What makes BÜHLMANN unique in the world of diagnostics? We have asked our customers, distributors and employees. Their answers can be symbolized up in the mascot of BÜHLMANN, the Saint Bernard Dogs, as they accompany us since 40 years. Saint Bernard dogs are unique, reliable and independent – and so is BÜHLMANN.
BÜHLMANN has become the prime calprotectin company within a few years, offering the broadest calprotectin product range with the automatable BÜHLMANN fCAL® ELISA and the quantitative Quantum Blue® Calprotectin rapid tests and the new immuno-turbidimetric BÜHLMANN fCAL® turbo assay. For automation on ELISA robots we will continuously offer new CE-marked protocols for our BÜHLMANN fCAL® ELISA, combined with our easy, safe and clean stool sampling and extraction CALEX® Cap device. With IBDoc® calprotectin, the smartphone based home testing solution, BÜHLMANN is bringing calprotectin monitoring to patients. In 2016, BÜHLMANN has launched its newest innovation the Quantum Blue® Infliximab rapid test allowing clinicians immediate determination of trough levels.
BÜHLMANN does not only stand for calprotectin, but also for a selection of unique, high-quality assays for clinical routine use such as the BÜHLMANN Flow CAST® product group for Basophil Activation Testing, and the BÜHLMANN GanglioCombi™ MAG ELISA , the only screening ELISA for anti-Ganglioside and anti-MAG antibody testing in one single assay.
BÜHLMANN continues to renew and enlarge its product portfolio, with the aim to be a leader in selected fields of in vitro diagnostics and in combining innovation with its traditional core values.
As unique as our products are our distribution fields with leading suppliers in the field of molecular diagnostics. With Seegene and the Anyplex™ II/Allplex™ products in combination with NIMBUS IVD/STARlet and the CFX96, we offer the leading automated high multiplex real-time PCR solution, with a unique menu, for all sizes of laboratories. With Quidel® and Meridian Bioscience® we offer a wide range of MDx POC tests that need no expensive instrument or equipment and with EntroGen and BioNTech® we offer outstanding MDx tests in the field of Oncology.
Quality is not just a statement, but part of our daily commitment. The Management System is EN ISO 13485:2016
certified and the products are manufactured according to GMP standards
. BÜHLMANN staff and distributors as well as selected customers are continually trained.
BÜHLMANN is known for the outstanding quality of its products, its excellent after sales services and a worldwide availability through a network of highly qualified distributors.
BÜHLMANN is a fully independent, medium sized and family owned Swiss company. The company was founded in 1976 and has continuously developed over the years. Sister companies have been established in Austria (BÜHLMANN in Austria GmbH) in 1996, in France (BÜHLMANN France SAS) in 2002, in Italy (BUHLMANN Italia srl) in 2009 and Brasil (BÜHLMANN Brasil) in 2013. In 2015, BUHLMANN Diagnostics Corporation has been established to serve customers in the USA and Canada. Since 2005, BÜHLMANN products are directly distributed in Germany.